Powered by Pharmaco-Net’s Insights.
Discover the results from AI-driven data analysis and novel drug candidate discovery
| No | Journal | Title | Year | DOI |
|---|---|---|---|---|
| 07 | EMM (Experimental & Molecular Medicine) |
Isobavachalcone reduces blood glucose and promotes muscle development via dipeptidyl peptidase-4 inhibition |
2026 | Link |
| 06 | Journal of Cheminformatics |
CaliciBoost: Performance-driven evaluation of molecular representations for caco-2 permeability prediction |
2025 | Link | 05 | Molecular Oncology |
Dammarenediol II enhances etoposide-induced apoptosis by targeting O-GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer |
2025 | Link |
| 04 | EMM (Experimental & Molecular Medicine) |
Comprehensive profiling of RNA modification-related genes identifies RNA m7G binding protein CBP20 as a therapeutic target for tumor growth inhibition |
2025 | Link |
| 03 | Briefings in Bioinformatics |
Impact of halogenation on scaffold toxicity assessed using HD-GEM machine learning model |
2025 | Link |
| 02 | Biomedicine & Pharmacotherapy |
Chiisanogenin enhances glucose uptake and lowers blood glucose via insulin signaling activation |
2025 | Link |
| 01 | PNAS |
ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development |
2025 | Link |
